Shock is a comprehensive disease characterized by insufficient capillary perfusion of the heart, brain, kidneys, and tissues, which leads to cell metabolism functional disorders and microcirculatory blood flow disorders. Antivasoactive drugs are often used clinically for treatment. Commonly used anti-vasoactive APIs can be divided into vasodilator APIs and vasoconstrictor APIs. Vasodilator APIs include α-receptor blockers, β-receptor agonists, dopamine receptor activating drugs, glucocorticoids, calcium antagonists, etc. Vasoconstrictor APIs are mainly used for shock caused by dilation of small arteries and low impedance, including α-receptor agonists, polypeptide vasoconstrictors, etc.

Protheragen-ING offers a full range of antishock vasoactive APIs to support the research of global customers.